Recommended Rate for Intravenous (IV) Iron Administration
IV iron should be administered as an undiluted slow bolus injection at 100 mg/min for ferric carboxymaltose (FCM), or over 15 minutes for a 1000 mg dose. 1
Administration Rates by Formulation
Different IV iron formulations have specific recommended administration rates:
Ferric Carboxymaltose (FCM)
- Standard rate: 100 mg/min as undiluted slow bolus injection 1
- Alternative: 1000 mg dose over 15 minutes 1
- Maximum dose: 1000 mg iron (20 mL FCM)/week 1
Iron Dextran (Low Molecular Weight)
- Standard administration: 1000 mg in 250 mL normal saline infused over 1 hour 1
- Test dose required: 25 mg test dose or slow initial infusion for 5 minutes to monitor for reactions 1
Ferric Gluconate
- Standard dose: 125 mg diluted in 100 mL of 0.9% sodium chloride infused over 1 hour 2
- Alternative: Undiluted as slow IV injection at rate of up to 12.5 mg/min 2
- Pediatric dosing: 0.12 mL/kg (1.5 mg/kg elemental iron) diluted in 25 mL 0.9% sodium chloride over 1 hour 2
Iron Sucrose
- Maximum individual dose: 200 mg as slow IV infusion 1
Ferumoxytol
- Standard dose: 510 mg followed by second 510 mg dose 1
- Alternative: 1020 mg over 15 minutes has been studied and found safe 3
Monitoring and Safety Considerations
Observation period: Patients should be observed for adverse effects for at least 30 minutes following each IV iron injection 1
Infusion reactions:
Dilution considerations:
Re-evaluation timing:
Practical Considerations
- Formulations capable of administering a replacement dose of 1000 mg in a single 15-60 minute visit are preferable for ambulatory patients 1
- For patients with chronic heart failure and iron deficiency, FCM is recommended with specific dosing based on body weight and hemoglobin levels 1
- The average iron deficit in patients with iron deficiency anemia is approximately 1500 mg, suggesting that a 1000 mg dose may be insufficient for complete iron repletion 4
Common Pitfalls to Avoid
Overestimation of transferrin saturation: Shortly after IV administration of iron preparations, spuriously high transferrin saturation levels may occur due to measurement of circulating drug iron 1
Inadequate dosing: A total cumulative dose of 1000 mg may be insufficient for iron repletion in most patients with iron deficiency anemia; 1500 mg is closer to the actual iron deficit 4
Inappropriate reaction management: Using vasopressors and H1 blockers for minor infusion reactions can convert them into hemodynamically significant adverse events 5
Excessive dilution: Over-diluting certain formulations like FCM can affect drug stability and efficacy 1
By following these specific administration rates and monitoring protocols, IV iron therapy can be administered safely and effectively to correct iron deficiency.